×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by PASQUALONE FRANK

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ENVBEnveric Biosciences, Inc.PASQUALONE FRANKDirectorSep 15, 2023Buy$2.141,0002,1401,000Sep 19, 2023, 05:34 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, CHIEF BUSINESS OFFICERNov 19, 2021Option Exercise$8.363,77931,592429,783Nov 23, 2021, 08:25 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Business OfficerAug 20, 2021Option Exercise$14.053,77953,095433,562Aug 24, 2021, 06:57 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Business OfficerFeb 20, 2021Option Exercise$18.7926,961506,597439,719Feb 23, 2021, 06:09 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2020Option Exercise$17.214,21472,523401,680Nov 24, 2020, 06:17 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2020Option Exercise$18.224,21476,779405,894Aug 24, 2020, 06:27 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2020Option Exercise$26.674,214112,387410,108May 22, 2020, 06:07 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2020Option Exercise$25.9024,392631,753412,920Feb 24, 2020, 07:10 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2019Option Exercise$17.602,44743,067318,312Nov 22, 2019, 06:22 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2019Option Exercise$21.512,33550,226320,759Aug 22, 2019, 06:02 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2019Option Exercise$19.841,60431,823323,094May 22, 2019, 06:09 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2019Option Exercise$27.004,919132,813323,671Feb 22, 2019, 06:16 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2018Option Exercise$24.795,735142,171216,340Nov 21, 2018, 05:45 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2018Option Exercise$26.955,735154,558222,075Aug 22, 2018, 07:33 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2018Option Exercise$24.3118,424447,887227,810May 22, 2018, 07:02 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2018Option Exercise$29.094,741137,916211,619Feb 22, 2018, 05:40 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2017Option Exercise$28.585,820166,336207,360Nov 22, 2017, 04:38 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 21, 2017Buy$26.344,000105,359213,180Aug 23, 2017, 05:04 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2017Option Exercise$27.405,820159,468209,180Aug 22, 2017, 06:29 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2017Option Exercise$36.835,820214,351215,000May 23, 2017, 08:00 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSVP Global Head Acute Care BusFeb 20, 2017Option Exercise$33.788,762295,980219,118Feb 22, 2017, 07:07 PM
TBPHTheravance Biopharma, Inc.PASQUALONE FRANKSr. VP, OperationsFeb 20, 2016Option Exercise$15.6510,830169,489127,178Feb 23, 2016, 07:55 PM